Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Medical Economics|June 1, 2017
A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapiesJesse D Ortendahl, Amanda L Harmon, Tanya G K Bentley, et al.
Archives of Internal Medicine|September 24, 2008
Trade-offs in cervical cancer prevention: balancing benefits and risksNatasha K Stout, Jeremy D Goldhaber-Fiebert, Jesse D Ortendahl, et al.
Current Medical Research and Opinion|November 15, 2021
Real-world impact of disease on functioning and activity: what is missed when using general instruments to estimate quality-adjusted life yearsTingjian Yan, Jesse D Ortendahl, Eunice Chang, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 2, 2017
Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitalsJesse D Ortendahl, Sonia J Pulgar, Beloo Mirakhur, et al.
Journal of Medical Economics|March 11, 2024
Value of next generation sequencing (NGS) testing in advanced cancer patientsJesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, et al.
Clinical Cardiology|October 16, 2018
Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?Jesse D Ortendahl, Allison L Diamant, Peter P Toth, et al.
JCO Precision Oncology|June 17, 2025
Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung CancerJesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, et al.
International Journal of Cancer|July 1, 2011
Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern AfricaNicole G Campos, Jane J Kim, Philip E Castle, et al.
American Journal of Clinical Oncology|September 24, 2015
Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United StatesVeena Shankaran, Jesse D Ortendahl, Anna G Purdum, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Costs associated with unplanned readmissions among patients with heart failure with and without hyponatremiaAlpesh N Amin, Jesse D Ortendahl, Amanda L Harmon, et al.
Pageof 2